| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-24669SS | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Phycoerythrin | FAB4315P | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | FAB4315P | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB4315-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26618-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-45051 | |||
![Western Blot: DLL3 Antibody [NBP2-24669] - Analysis of DLL3 in mouse embryo brain lysate in the 1) absence and 2) presence of immunizing peptide and 3) T98G cell lysate using DLL3 antibody at 3 and 5 ug/mL respectively. Goat anti-rabbit Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/DLL3-Antibody-Western-Blot-NBP2-24669-img0001.jpg "Western Blot: DLL3 Antibody [NBP2-24669] - Analysis of DLL3 in mouse embryo brain lysate in the 1) absence and 2) presence of immunizing peptide and 3) T98G cell lysate using DLL3 antibody at 3 and 5 ug/mL respectively. Goat anti-rabbit Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![Immunohistochemistry-Paraffin: DLL3 Antibody [NBP2-24669] - Human brain tissue probed with an isotype control (top) and DLL3 antibody (bottom) at 5 ug/mL.](http://images.novusbio.com/fullsize/DLL3-Antibody-Immunohistochemistry-Paraffin-NBP2-24669-img0002.jpg)
![ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.625-2.702 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-262202412272346.jpg "ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.625-2.702 ng/mL.")
![ELISA: DLL3 Antibody (7B7) [NBP3-26618] - The Binding Activity of DLL3 with DLL3 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized DLL3 at 2 ug/mL can bind DLL3 Antibody, the EC50 is 1.102-1.707 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-262202412272316.jpg)
![Flow Cytometry: DLL3 Antibody (7B7) [NBP3-26618] - Untransfected HEK293 cells (green line) and transfected Human DLL3 HEK293 stable cells (red line) were stained with anti-DLL3 antibody (rovalpituzumab-like) (2ul/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG1 Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26618_human-dll3-mab-7b7-282202414312733.jpg)
![Western Blot: DLL3 Antibody [NBP3-10597] - Western blot analysis of DLL3 in Hela Whole cell lysates. Antibody dilution at 1.0ug/ml](http://images.novusbio.com/fullsize/DLL3-Antibody-Western-Blot-NBP3-10597-img0001.jpg "Western Blot: DLL3 Antibody [NBP3-10597] - Western blot analysis of DLL3 in Hela Whole cell lysates. Antibody dilution at 1.0ug/ml")
![ELISA: Human DLL3 - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-31368] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-31368_human-dll3-ready-to-use-elisa-kit-colorimetric-20620241525240.png "ELISA: Human DLL3 - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-31368] - Standard Curve Reference")